EFPIA Urges Adoption of Anticounterfeiting Measure - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

EFPIA Urges Adoption of Anticounterfeiting Measure


ePT--the Electronic Newsletter of Pharmaceutical Technology

Untitled Document

Brussels (May 30)—The European Federation of Pharmaceutical Industries and Associations (EFPIA) called for the pan-European and industry-wide adoption of 2-D barcode technology to combat the increase in counterfeit drugs in Europe.

EFPIA proposed that every medicine pack in Europe have a 2-D data-matrix barcode printed on the packaging. The barcode would be encrypted and have a randomized number that is unique to each pack, making it difficult for counterfeiters to copy the barcodes and introduce counterfeit drugs into the legitimate supply chain. The code could be read by any handheld barcode scanner and would provide a chain of custody wherever it is scanned.

Counterfeit medicines have become a subject of increasing concern in Europe.  The European Commission recently released figures that show a dramatic rise in the number of counterfeit medicines in the legitimate supply chain. The pharmaceutical industry is working to increase public awareness of the problem and come up with a feasible anticounterfeiting solution.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
Source: ePT--the Electronic Newsletter of Pharmaceutical Technology,
Click here